Workflow
Intercept Blood System
icon
Search documents
Cerus: IFC Growth And RBC Optionality (NASDAQ:CERS)
Seeking Alpha· 2025-11-24 04:07
Core Insights - Cerus Corporation (CERS) is a biotechnology company focused on developing transfusion-safety solutions to ensure a reliable and pathogen-reduced blood supply [1] Group 1: Company Overview - Cerus Corporation produces the Intercept Blood System, which includes devices, disposables, and consumables for platelets and plasma [1]
Cerus: IFC Growth And RBC Optionality
Seeking Alpha· 2025-11-24 04:07
Core Insights - Cerus Corporation (CERS) is a biotechnology company focused on developing transfusion-safety solutions to ensure a reliable and pathogen-reduced blood supply [1] Group 1: Company Overview - Cerus Corporation produces the Intercept Blood System, which includes devices, disposables, and consumables for platelets and plasma [1]